Web notes  

March 2019

Third Thursdays with the ICTR Lecture Series

Next Lecture: March 21, 2019, 10:00 AM - 11:00 AM, Woods Basic Science Auditorium (PCTB)

"MyPath Story Booth Project"
Lily Su, BS
Research Program Manager
Johns Hopkins School of Nursing

Download the event flyer. Register now!

This series showcases many of the resources, programs, educational training and other opportunities we offer. Those tools are designed to transform the translational process so that new treatments and cures for disease can be delivered to patients faster. On the third Thursday of the month, speakers will present a topic that can directly aid clinical research study team members.

We encourage all faculty, staff and students to attend. There will be a question and answer period at the close of each lecture. If you have suggestions for future topics, feel free to contact us.

Clinical Research Annual Reports

Clinical research is one of the most complex, yet rewarding missions of Johns Hopkins Medicine. This past year over 600 research teams across Johns Hopkins Medicine, from our academic sites to our community-based sites, have contributed in many ways to our understanding of what treatments work best for patients. We have created an integrated set of annual reports from the programs that support clinical research to let research teams know how we can work together.

Clinical trial activity continues to increase at Johns Hopkins with impressive growth in the last year.

  Active Clinical Trials Consented Patients
2017 Q2 1,132 13,408
2018 Q2 1,237 17,511

We are particularly pleased that the number of research participants who just enrolled in the clinical trials has also increased. Comparing 2017Q2 to 2018Q2 there was a 16% increase in the number of research participants who had recently consented to join a clinical trial.

Even with this growth, our measures of research participant satisfaction are particularly gratifying. For the past three years, every 6 months we send out surveys to 500 randomly selected individuals who have recently participated in a clinical trial as classified in CRMS. The survey was designed in partnership with our ICTR Community Research Advisory Council. The results are posted on the ICTR website for the public to review. Highlights of these results include:

  • 75% of research participants rate their overall experience as a 9 or 10 on a ten point scale
  • 96% would recommend to friends or family they should join a research study.
  • 97% reported the consent form prepared them for the study
  • 92% reported they were always treated with respect and courtesy by the research team
  • 88% reported that they usually or always they felt like they were a valued partner in the research process.

There are areas where we can still improve our performance with research participants. Research participants consistently comment on longer than expected wait times before or between research procedures. They also would like to learn more about the results of the study. A small, but persistent number, of research participants are commenting on higher out-of-pocket costs related to the usual care component of clinical trials and delays in receiving reimbursement or payment for their research participation.

There are many research offices than can help research teams. Please review these annual reports to determine if you are using all of the resources and expertise that is available. If you have suggestions about how these programs might function better, please send an email to ictr@jhmi.edu.


2018 Annual Reports

Research Participant Survey Results

Change in JHM IRB Review Fees for Commercially-Funded Studies

The JHM IRB bills for review of commercially-funded studies with financial support in excess of $10,000. The fees collected from reviewing commercially-funded studies help fund services provided by the IRB. To help cover the costs of IRB review for study closures and the compliance monitoring activities for select commercially-funded studies, the IRB review fees will be modified as of August 1, 2018.

The changes in IRB review fees include the following:

  • Inclusion of IRB review fees for study closures for commercially-funded studies
  • Inclusion of fees for select studies that require monitoring by the Office of Human Subjects Research Compliance Monitoring Program.

Any new study submitted on or after August 1, 2018 will be subject to the new fee schedule. After reviewing fee structures at similar institutions conducting human subjects research, we have determined the new fees to be in line or below the national average. For more information including a table with the new fees, visit https://www.hopkinsmedicine.org/institutional_review_board/news/letters_dean/archive/

Data and Safety Monitoring Board Training Manual Now Available

The Clinical and Translational Science award (CTSA) Collaborative Data and Safety Monitoring Board (DSMB) Workgroup identified a need to provide guidance, training and resources in DSMB practices for investigator-initiated research studies. To promote clinical and translational research, the CTSA Collaborative DSMB Workgroup, supported by NCATS, has produced an online DSMB Training Manual with a focus on investigator-initiated studies. This manual provides information and training for Principal Investigators, DSMB members, IRB members, biostatisticians, and research staff on how to work effectively with DSMBs. To read more about the manual and to access the manual, visit: https://ictr.johnshopkins.edu/news_announce/data-and-safety-monitoring-board-training-manual-now-available/

Good Clinical Practice (GCP) Fundamentals: Understanding and Applying GCP to Human Subject Research

Good Clinical Practice or 'GCP' training for investigators and study-team members is increasingly becoming required by institutions, sponsors, and the NIH. This 90 minute course will explain the elements of the International Conference for Harmonization's (ICH) principles and specific guidelines for Good Clinical Practice. Attendees will be introduced to the GCP Principles, and will explore investigator responsibilities in human subject research, focusing on the areas of trial conduct (experience, resources, and physician duties); performance (communication with the IRB, protocol compliance, and investigational product management); ethical research (safety oversight and informed consent); and recording/reporting (data acquisition, progress summaries, and safety-event reporting).

These training sessions are held the fourth Friday of each month. Register here: http://lms14.learnshare.com/l.aspx?CID=89&A=2&T=339728

Fee Schedule Adjustment for Hospital Services Charged to Clinical Trial Budgets

Please note the following information for clinical investigators from Dr. Daniel Ford, Vice Dean for Clinical Investigation. You may also get more information at our Clinical Research Revenue Cycle Resources web page: https://www.hopkinsmedicine.org/research/

The Executive Committee for Clinical Research Billing, consisting of senior research, legal, compliance and finance executives for Johns Hopkins Medicine met in December 2018 to review and update the research charge adjustment percentages.

For statements generated after March 1, 2019 Hospital Billing (HB) charges will be reduced to 36.5% of the facility charge master for Government/Not for Profit organizations and 59.7% for Pharmaceutical/For Profit sponsors. These reductions maintain parity with our target guideline of 100% of CMS Medicare rates for Government/Not for Profit sponsors and 150% of CMS Medicare rates for Pharmaceutical/For Profit companies. For comparison, 2018 guidance provided for reductions of 35.7% and 53.6% respectively.
Monthly Single Billing Office (SBO) account statements for research accounts with HB charges will continue to include a memo highlighting the charge master total, research rate adjustment, and reduced balance for payment from the study IO#.

Your support and cooperation is appreciated as we continue to improve administrative processes supporting clinical research. Study teams should contact the Clinical Research Support Services (CRSS) team to access pricing and develop budgets that ensure financial integrity of research projects. Please contact that group at crss@jhmi.edu or via phone at 410-361-8362.

Change in Federalwide Assurance [FWA] Numbers

Effective November 1, 2017 we are making changes to streamline the number of FWAs held by the institution and ensure that each legal entity has one FWA. This change will require closing out some existing FWAs assigned to organizations that are components under either the Johns Hopkins School of Medicine FWA number or The Johns Hopkins Health System FWA number. Functionally nothing else regarding IRB review or our human research protections program will change. However, organizational components should please take note of the new FWA that will be affiliated with each component and ensure only the two FWAs listed below are referenced moving forward.

FWA Numbers & Components:

The Johns Hopkins University School of Medicine [FWA00005752]
Includes the following components:

  • The Johns Hopkins School of Medicine
  • The Johns Hopkins University School of Nursing
  • The Johns Hopkins University Applied Physics Laboratory

The Johns Hopkins Hospital and Johns Hopkins Health Systems [FWA00006087]
Includes the following components:

  • All Children's Health System, Inc.
  • Howard County General Hospital
  • Johns Hopkins All Children's Hospital, Inc.
  • Johns Hopkins Bayview Medical Center
  • Johns Hopkins Community Physicians
  • Johns Hopkins Regional Physicians, LLC
  • Johns Hopkins Hospital
  • Sibley Memorial Hospital
  • Suburban Hospital and Health System

The following separate FWAs should no longer be referenced as of November 1, 2017:

  • All Children's Hlth System, Inc., FWA00000977 - expires10/17/18
  • The Johns Hopkins University School of Nursing, FWA00006088-expires 6/4/2019
  • Johns Hopkins Bayview Medical Center, FWA00006089-expires 3/6/2022
  • The Johns Hopkins University Applied Physics Laboratory, FWA00018613 - expires 3/6/2022
  • Johns Hopkins Community Physicians, FWA00002251-expires 3/13/2022
  • Howard County General Hospital, FWA00005743-expires 1/27/2020
  • Sibley Memorial Hospital, FWA00003508 - expires 8/13/18
  • Suburban Hospital and Health System - FWA00005924 - expires 3/6/2022

For additional questions about FWAs please visit: https://www.hhs.gov/ohrp/regulations-and-policy/guidance/faq/assurance-process/index.html

For questions regarding the changes to our existing FWAs, please contact Megan Kasimatis Singleton, Assistant Dean for Human Research Protection at msingl16@jhmi.edu or (443) 287-0204.

Changes to NIH-funded Human Subjects Research

If you are conducting NIH-funded research that involves human subjects, or are considering applying to NIH for support of such research, please note important changes that may affect how you:

  • select the right NIH funding opportunity announcement
  • write the research strategy and human subjects sections of your application
  • comply with appropriate policies and regulations

First, familiarize yourself with the new PHS Human Subject and Clinical Trial Information form. For application due dates of January 25, 2018, and beyond, you will be required to use an updated application forms package (FORMS-E), which includes the new human subject and clinical trial form. This form requests human subject and clinical trials information at the study level using discrete form fields, which is a change from current practice. Contract proposals will also require this information. Learn about the new form here.

Second, take a moment to answer these four questions about your current or proposed research:

  1. Does the study involve human participants?
  2. Are the participants prospectively assigned to an intervention?
  3. Is the study designed to evaluate the effect of the intervention on the participants?
  4. Is the effect that will be evaluated a health-related biomedical or behavioral outcome?

If the answer to all four questions is yes, then your proposed research meets the NIH definition of a clinical trial. Clarified and broadened in 2014, the definition encompasses a wide range of trial types: mechanistic, exploratory/developmental, pilot/feasibility, behavioral, and more. NIH expanded the clinical trial definition in response to widespread calls from diverse stakeholders for improved reporting of research milestones and outcomes, and for assuring maximal transparency.

Need help determining whether your study would be considered by NIH to be a clinical trial? See the NIH webpage on the definition that includes case studies, FAQs and other resources that can help. Still unsure? Contact your NIH program official or the scientific point of contact listed on the funding opportunity announcement to which you are applying.

Third, familiarize yourself with NIH policy changes related to enhancing stewardship of clinical trials.

NIH made a number of policy changes to improve the stewardship of clinical trials across the life cycle of the trial. Familiarize yourself with all that is changing, including:

  • the requirement to apply to an FOA that specifically allows for the submission of clinical trial applications for due dates beginning January 25, 2018.
  • Good Clinical Practice training expectations for NIH staff, grantees, and contractors that went into effect January 2017.
  • updated peer review criteria that will be included in FOAs for clinical trial applications and solicitations for due dates on/after January 25, 2018.
  • new Human Subject Information form requirements for clinical trials that will be included in updated application forms (FORMS-E) for due dates on/after January 25, 2018, and contract solicitations published as of January 25, 2018.
  • use of a single IRB for non-exempt, multi-site clinical trials for application due dates on/after January 25, 2018.
  • expanded ClinicalTrials.gov registration and reporting to include all NIH supported clinical trials.

Improving the design, efficiency, and transparency of clinical trials is important because it:

  • respects our ethical obligation to participants to maximize the use of the knowledge from the trials in which they participate
  • facilitates design of clinical trials while reducing unnecessary duplication
  • promotes broad, timely, and responsible dissemination of research information and results
  • fosters responsible stewardship of the public's investment in biomedical research

The NIH has developed a new Clinical Trial Requirements for NIH Grantees and Contractors web page to bring together all the information you need to know.

Please review this information carefully. Your attention to detail will be critical to ensuring successful funding of your clinical trial awards.

The NIH will be putting out a series of reminder policy notices, training opportunities, and other resources in the NIH Guide to Grants and Contracts, in the NIH Extramural Nexus, and on this blog.

Free Resources for Longitudinal Clinical Research Studies

A Department of Medicine faculty member is a PI on a large NHLBI R24 "national infrastructure" grant. This NIH grant aims to provide resources for longitudinal clinical research studies. The following resources are freely available from the project's website (http://www.improveLTO.com):

  1. Database of common patient-reported and performance-based outcome measures, and standardized information about these measures (includes physical, cognitive, mental health and quality of life outcomes);
  2. Adaptable tools, templates, and manuals to maximize cohort retention (including an interactive database with >600 retention strategies abstracted from a recent systematic review);
  3. A statistical tool to address the competing risk of mortality (i.e. truncation due to death) when evaluating functional outcomes.

NIH requirement for Single IRB (sIRB)

Effective September 25, 2017, the NIH requires that all grant applications for domestic, multi-site, non-exempt human subject research studies include a proposal for the use of a single IRB ("sIRB") to review the research for all participating domestic sites. The JHSPH IRB, the SOM IRB, and the Homewood IRB are working together to address the new NIH requirement for sIRB. When sIRB services are required by a Sponsor, and a JHU PI wants JHU to serve as the study's sIRB, the SOM IRB will review all requests for sIRB services, and if approved, will serve as the University's sIRB for all divisions. JHU has signed on to the SMART IRB Reliance agreement, and investigators are urged to make sure that their collaborators have either signed on to this form of reliance agreement, or are willing to sign on.

  • All Planning Phase and New Applications that involve Hopkins as the reviewing sIRB must submit a "Reliance Request" through an on-line SOM IRB query portal available on this page: http://www.hopkinsmedicine.org/institutional_review_board/about/
    . Reviewers will evaluate and act on the request. SOM faculty will use the same portal for applications seeking to rely on an external sIRB.
  • JHSPH and Homewood investigators preparing grant submissions and new applications that propose relying on an external sIRB should contact the JHSPH (jhsph.irboffice@jhu.edu) or Homewood IRB (hirb@jhu.edu) for further guidance.

All other reliance requests will be managed by the IRB associated with the PI's division. Please contact JHMIRBreliance@jhmi.edu with questions about the SOM IRB sIRB process.

JHM IRB Reliance Requests

JHM IRB is willing to review requests for reliance on an external IRB as well as requests for JHM to act as the IRB of record. Typically, requests for reliance are submitted to our IRB at two time points:

a) when studies are in their planning stages, and
b) when studies are ready to be submitted for IRB review

The first step in the reliance request process is to complete a reliance request. The JHM IRB reliance team will review the information provided in the reliance request and will contact you with next steps.

For more information about the JHM reliance, please visit: http://www.hopkinsmedicine.org/institutional_review_board/about/reliance_agreement.html

Sharing Partnership for Innovative Research in Translation

A funding partnership among seven prestigious universities - including the Johns Hopkins Institute for Clinical and Translational Research - are awarding nearly $300,000 to scientists working on collaborative research among their institutes that will explore widely ranging health concerns, from creating tumor-destroying viruses to decreasing the large numbers of mentally ill in the criminal justice system.

The Sharing Partnership for Innovative Research in Translation (SPIRiT) consortium has offered this funding of research since 2012, awarding more than $1 million to 12 collaboration projects.

The SPIRiT consortium is made up of six National Institutes of Health (NIH) Clinical and Translational Science Awards (CTSA) Programs, including the Johns Hopkins University Institute for Clinical and Translational Research, University of Pennsylvania's Institute for Translational Medicine and Therapeutics, University of Pittsburgh's Clinical and Translational Science Institute, Washington University in St. Louis' Institute of Clinical and Translational Sciences, Yale University's Center for Clinical Investigation, and the Institute for Translational Medicine (ITM), a partnership between the University of Chicago and Rush.

For more information on the Johns Hopkins awardee for this program as well as details on the individual projects, visit our webpage.

Johns Hopkins Institute for Clinical and Translational Research

The Johns Hopkins Institute for Clinical and Translational Research (ICTR) offers many clinical resources for faculty and student investigators, including outpatient and inpatient space for studies in clinical research units, patient recruitment tools, collaboration opportunities, and various tools to protect patient data. To see all the services offered by the ICTR, visit the ICTR website.

Johns Hopkins Clinical Research Network

The Johns Hopkins Clinical Research Network (JHCRN) is an all-in-one resource for linking investigators to regional community-hospital based collaborators for the success of investigator-initiated and industry funded studies. Please visit the JHCRN website to learn more about this network: http://ictr.johnshopkins.edu/clinical/clinical-resources/human-subjects-research-core/jhcrn/.

Return to top of Human Subjects Research

March 2019 articles:
Third Thursdays with the ICTR Lecture Series
Clinical Research Annual Reports
Change in JHM IRB Review Fees for Commercially-Funded Studies
Data and Safety Monitoring Board Training Manual Now Available
Good Clinical Practice (GCP) Fundamentals: Understanding and Applying GCP to Human Subject Research
Fee Schedule Adjustment for Hospital Services Charged to Clinical Trial Budgets
Change in Federalwide Assurance [FWA] Numbers
Changes to NIH-funded Human Subjects Research
Free Resources for Longitudinal Clinical Research Studies
NIH Requirement for Single IRB (sIRB)
JHM IRB Reliance Requests
Sharing Partnership for Innovative Research in Translation
Johns Hopkins Institute for Clinical and Translational Research
Johns Hopkins Clinical Research Network
Visit Animal Care and Use Committee Website
Current Classes
"Interinstitutional Assurance" Agreement
Health, Safety, and Environment (HSE) presents: Safety in Research Updates
Johns Hopkins University | Emerson Collective Cancer Research Fund Request for Proposals
William T. Grant Scholars Program
Michael J. Fox Foundation (MJFF) Challenge
JHU SOM Update on NIH Policy on Foreign Involvement
Disclosure of Payments from Foreign Educational Institutions and Government Agencies
New Institutional Letter of Support Required for Institutional Training Grant Applications
Notice to the Johns Hopkins Community Regarding the National Science Foundation Grant Reporting Requirement for Harassment Findings and Actions
Prohibited Mention of Prior Review for New Replacement Applications
NIH Policy on Foreign Component Involvement
Why Project Outcomes Matter in your Interim and Final Research Performance Progress Report (RPPR)
NIH Matchmaker, A Tool For Finding Similar NIH Projects
NIH Video Tutorials on How to Apply for Grants

This Month's Departmental Listings

Upcoming Deadlines for March, April, and May

Upcoming Events


JHM AppointmentsEmployment @ JHM | Finding a Doctor | Disclaimer | Maps & Directions | Contact JHM 


                                                                                                                                                           The Web Center